Stock Price
219.38
Daily Change
-0.02 -0.01%
Monthly
-11.46%
Yearly
-3.21%
Q1 Forecast
212.82

Date Reference Time Actual Consensus Previous
2026-05-20 FY2026Q4 PM 2.86 2.74
2026-02-04 FY2026Q3 PM 2.53 2.53 2.32
2025-11-05 FY2026Q2 PM 2.47 2.36 2.14
2025-08-06 FY2026Q1 PM 2.34 2.26 2.03
2025-05-14 FY2025Q4 PM 2.74 2.60 2.41



Peers Price Chg Day Year Date
Olympus 1,488.50 -1.50 -0.10% -22.68% Mar/31
Accuray 0.34 -0.06 -14.14% -81.01% Mar/30
Avanos Medical 13.73 0.21 1.55% -4.19% Mar/30
Baxter International 15.80 -0.17 -1.06% -53.84% Mar/30
Becton, Dickinson and Co. 154.69 0.18 0.12% -32.47% Mar/30
Boston Scientific 62.92 -6.25 -9.04% -37.63% Mar/30
CONMED 33.49 -1.09 -3.15% -44.54% Mar/30
Cooper Companies 69.31 -0.46 -0.66% -17.83% Mar/30
Dexcom 61.90 -0.35 -0.56% -9.36% Mar/30
Ecolab 262.43 1.06 0.41% 3.51% Mar/30

Indexes Price Day Year Date
US400 3284 -27.09 -0.82% 12.49% Mar/30
US2000 2414 -35.69 -1.46% 19.99% Mar/30
US500 6417 -25.13 -0.39% 13.92% Mar/31

Steris traded at $219.38 this Monday March 30th, decreasing $0.02 or 0.01 percent since the previous trading session. Looking back, over the last four weeks, Steris lost 11.46 percent. Over the last 12 months, its price fell by 3.21 percent. Looking ahead, we forecast Steris to be priced at 212.82 by the end of this quarter and at 194.23 in one year, according to Trading Economics global macro models projections and analysts expectations.

Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It’s Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.